MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 130 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $125,000 | -59.4% | 30,550 | -37.1% | 0.01% | -61.5% |
| Q3 2016 | $308,000 | +17.6% | 48,550 | 0.0% | 0.01% | +18.2% |
| Q2 2016 | $262,000 | -35.5% | 48,550 | 0.0% | 0.01% | -35.3% |
| Q1 2016 | $406,000 | +5.7% | 48,550 | 0.0% | 0.02% | +13.3% |
| Q4 2015 | $384,000 | -34.0% | 48,550 | -29.0% | 0.02% | -34.8% |
| Q3 2015 | $582,000 | -31.1% | 68,365 | 0.0% | 0.02% | -17.9% |
| Q2 2015 | $845,000 | +4.1% | 68,365 | 0.0% | 0.03% | +7.7% |
| Q1 2015 | $812,000 | +5.0% | 68,365 | 0.0% | 0.03% | +4.0% |
| Q4 2014 | $773,000 | – | 68,365 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,211,880 | $17,474,000 | 4.63% |
| Parametrica Management Ltd | 21,228 | $168,000 | 1.11% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $653,000 | 0.73% |
| Virtus ETF Advisers LLC | 33,570 | $265,000 | 0.73% |
| Opus Point Partners Management, LLC | 122,500 | $968,000 | 0.64% |
| NEXTHERA CAPITAL LP | 36,000 | $284,000 | 0.40% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7,255,815 | $57,321,000 | 0.39% |
| Cannell & Co. | 1,051,178 | $7,751,000 | 0.25% |
| Tekla Capital Management LLC | 853,787 | $6,745,000 | 0.24% |
| STONERIDGE INVESTMENT PARTNERS LLC | 208,282 | $1,645,000 | 0.22% |